UBS Group’s VSEE HEALTH INC VSEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.79K Buy
35,160
+7,861
+29% +$2.67K ﹤0.01% 8482
2025
Q4
$10.2K Buy
27,299
+25,836
+1,766% +$17K ﹤0.01% 8237
2025
Q3
$892 Sell
1,463
-51,046
-97% -$50K ﹤0.01% 9505
2025
Q2
$60.9K Sell
52,509
-37,641
-42% -$43.2K ﹤0.01% 7614
2025
Q1
$108K Buy
90,150
+30,623
+51% +$45.3K ﹤0.01% 6991
2024
Q4
$81K Buy
59,527
+50,866
+587% +$75.7K ﹤0.01% 7002
2024
Q3
$12.9K Buy
+8,661
New +$27.7K ﹤0.01% 7609
2023
Q1
Sell
-1,348
Closed -$14.3K 10534
2022
Q4
$14.3K Sell
1,348
-774
-36% -$8.07K ﹤0.01% 8087
2022
Q3
$22K Buy
2,122
+100
+5% +$1.01K ﹤0.01% 7280
2022
Q2
$20K Buy
2,022
+1,922
+1,922% +$19.3K ﹤0.01% 6891
2022
Q1
$1K Buy
+100
New +$994 ﹤0.01% 9950

Other funds holding VSEE

UBS Group's VSEE Position: Q1 2026 in Review

UBS Group increased its VSEE HEALTH INC (VSEE) stake by 29% in Q1 2026, buying an estimated $2.67K and bringing the position to 35,160 shares worth $8.79K. The position accounts for ﹤0.01% of the portfolio, ranked #8482.

UBS Group first reported a position in VSEE in Q1 2022 and has held it in 11 quarters since. The position peaked at $108K in Q1 2025. 14 funds tracked by Wall St. Rank hold VSEE as of Q1 2026.

  • UBS Group held 35,160 shares of VSEE HEALTH INC worth $8.79K as of Q1 2026.
  • UBS Group bought 7,861 VSEE HEALTH INC shares in Q1 2026, an estimated $2.67K.
  • VSEE HEALTH INC made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #8482 holding.
  • UBS Group first reported a position in VSEE HEALTH INC in Q1 2022 and has held it in 11 quarters since.
  • UBS Group's VSEE HEALTH INC position peaked at $108K in Q1 2025.
  • 14 funds tracked by Wall St. Rank held VSEE HEALTH INC as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.